Advanced Laser and Anti-Aging Medical Center in Pasadena, California is pleased to offer the new and revolutionary treatment for below-the-chin fat, Kybella®. Known to effectively downsize that bothersome “double chin” by destroying fat cells, FDA-approved Kybella injections can improve your facial profile in 6 treatments or less.
Kybella (deoxycholic acid) is a minimally invasive, FDA-approved medication used to minimize moderate to severe fat below the chin — also called a “double chin” — in adults. Injected into the area, deoxycholic acid effectively destroys the fat cells’ membranes so they collapse, making it easier for your body to absorb or eliminate the fat.
Dr. Seltzer will customize a treatment plan, based on your chin profile and goals. He has found that at least 2-3 treatments are typically needed or Kybella to effectively begin eliminating fat. Adults may receive a maximum of 6 treatments, spaced at least one month apart.
Results vary, but clinical studies have shown that nearly 60% of patients who received 6 treatments of Kybella experienced visible results within 2 to 4 treatments. After one treatment, patients have gleaned an average of 8% improvement in chin fat appearance, and a 72% improvement after 6 treatments.
Like most medications, Kybella may cause side effects. The most common include bruising, swelling, numbness, pain, redness and hardness in the treatment area and facial or muscle weakness. Less likely, but more severe, potential side effects include trouble swallowing and nerve injury in the jaw that can cause facial muscle weakness or an uneven smile.
Once Kybella is injected and destroys fat cells, they cannot accumulate or store fat again. In other words, once you’ve reached your desired look, you won’t likely need more treatments.
Children and anyone experiencing an infection in the treatment area should not receive Kybella injections. Before treatments, tell Dr. Seltzer about any medical conditions or symptoms you have, as well as if you are pregnant or breastfeeding. The effects of Kybella on unborn babies and breastmilk aren’t known.